Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis
Abstract Objective No efficacious treatments exist to improve or prolong bulbar functions of speech and swallowing in persons with amyotrophic lateral sclerosis (pALS). This study evaluated the short‐term impact of dextromethorphan/quinidine (DMQ) treatment on speech and swallowing function in pALS....
Autori principali: | Lauren Tabor Gray, Eduardo Locatelli, Terrie Vasilopoulos, James Wymer, Emily K. Plowman |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Wiley
2023-08-01
|
Serie: | Annals of Clinical and Translational Neurology |
Accesso online: | https://doi.org/10.1002/acn3.51821 |
Documenti analoghi
Documenti analoghi
-
Diagnostic utility of the amyotrophic lateral sclerosis Functional Rating Scale-Revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis.
di: Jennifer L Chapin, et al.
Pubblicazione: (2020-01-01) -
Combined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis
di: Raele Robison, et al.
Pubblicazione: (2018-09-01) -
The effect of acute administration of quinidine, dextromethorphan and combination of dextromethorphan/quinidine on pentylenetetrazole-induced clonic and tonic seizure thresholds in mice
di: Hassan Jamali, et al.
Pubblicazione: (2019-08-01) -
Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease
di: Rita Khoury
Pubblicazione: (2022-01-01) -
Effects of noninvasive ventilation in amyotrophic lateral sclerosis: The complication of bulbar impairment
di: Junghyun Kim, et al.
Pubblicazione: (2020-03-01)